Clinical Trial Update: Duloxetine for Multiple Sclerosis Pain [Phase 3]

View source ↗

Summary

Phase 3 trial results investigating duloxetine for multiple sclerosis-related pain have been completed, with results posted in 2011. The sponsor is Eli Lilly an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2011-12-09